Pulse Biosciences closes private placement of 10M shares to Executive Chairman at $6.51

PULSE BIOSCIENCES, INC.

Robert W. Duggan, Executive Chairman and majority stockholder, purchased 10,022,937 shares at $6.51 per share.
Price represents a ~1% premium over the $6.44 NASDAQ closing price on April 28, 2023.
Transaction under Securities Purchase Agreement dated April 30, 2023, consummated on May 9, 2023.

item 1.01 item 1.02 item 3.02

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

PULSE BIOSCIENCES, INC. entered into Securities Purchase Agreement with Robert W. Duggan (effective 2023-04-30).

Action: entry
Agreement: equity purchase
Counterparty: Robert W. Duggan
Effective: 2023-04-30

Exact text from the filing

On May 9, 2023, the transactions contemplated by that certain Securities Purchase Agreement dated as of April 30, 2023 (the “Purchase Agreement”) between Pulse Biosciences, Inc. (the “Company”) and Robert W. Duggan, the Company’s Executive Chairman of the Board of Directors and majority stockholder of the Company, were consummated.

View on SEC.gov

Browse all material agreements →

PULSE BIOSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0001437749-23-013339

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.